Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 2.62 M2.6 M2.85 M2.98 M3.01 M2.87 M 11.71 M Research & development —————— — Operating income 24.59 M34.6 M29.01 M28.54 M30.02 M29.68 M 117.24 M Non-Operating Income, Total 139 K3.69 M212 K235 K824 K349 K 1.62 M Interest expense, net of interest capitalized 13.55 M14.04 M14.51 M14.5 M14.45 M14.81 M 58.26 M Non-Operating Income, excl. Interest Expenses -13.41 M-10.35 M-14.29 M-14.26 M-13.63 M-14.46 M -56.64 M Unusual income/expense —————— — Pretax income 15.42 M21.53 M18.87 M19.69 M18.49 M18.65 M 75.7 M Equity in earnings —————— — Taxes 3.83 M5.04 M4.48 M4.22 M4.2 M4.18 M 17.08 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 11.6 M16.49 M14.39 M15.47 M14.29 M14.47 M 58.62 M Discontinued operations —————— — Net income 11.6 M16.49 M14.39 M15.47 M14.29 M14.47 M 58.62 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 11.6 M16.49 M14.39 M15.47 M14.29 M14.47 M 58.62 M Basic earnings per share (Basic EPS) 1.151.641.431.551.431.44 5.85 Diluted earnings per share (Diluted EPS) 1.131.611.411.521.41.42 5.75 Average basic shares outstanding 10.05 M10.03 M10.04 M10.03 M10.01 M10.04 M — Diluted shares outstanding 10.25 M10.21 M10.23 M10.22 M10.2 M10.22 M — EBITDA 10.67 M20.11 M14.08 M13.6 M15.08 M14.32 M 57.08 M EBIT 10.66 M20.13 M14.1 M13.63 M15.16 M14.4 M 57.29 M Cost of revenue 1.36 M1.73 M1.41 M2.26 M1.04 M1.04 M 5.75 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) -16 K-20 K-24 K-25 K-80 K-80 K -209 K